The controversy over patenting genes took a new twist in February, when a
patients group got in on the act. PXE International patented methods of treating
the debilitating genetic disease PXE based on the MRP6 gene. Mutations
in MRP6 are to blame for the disease. The group hopes that owning the
gene will allow it to accelerate research, control licence fees and prevent turf
wars between scientists.
To continue reading, today with our introductory offers
Advertisement
More from Â鶹´«Ã½
Explore the latest news, articles and features
Popular articles
Trending Â鶹´«Ã½ articles
1
We've found a mysterious substance on Titan and Pluto
2
Gas from Uranus reveals it has an icy centre
3
Has the answer to life's origins been hiding in our cells all along?
4
Can prebiotics, probiotics or postbiotics help your ageing microbiome?
5
Faecal transplant makes the brains of old mice act young again
6
Carl Sagan's The Demon-Haunted World is still supremely relevant today
7
Why you need to future-proof your brain in middle age and how to start
8
Almost the whole of Japan moved eastward after 2011 earthquake
9
Toy universe shows that time could be a quantum illusion
10
A quantum state that lasts forever may finally be within our grasp
